[Contribution to the analysis of the mechanism of rebound phenomenon development following beta blockers (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D005260:Female; D006321:Heart / Q000187:drug effects*; D008297:Male; D014290:Metipranolol / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical
D000319:Adrenergic beta-Antagonists; D014290:Metipranolol
Príspevok k analýze mechanizmu vzniku "rebound" fenoménu po betalytikách.